Data / Drug companies / Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.: 20 products in the FDA NDC directory, labeler code 42513
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (labeler code 42513) lists 20 products in the FDA National Drug Code Directory. By type: 20 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 14, 2024.
The request: Watch Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (FDA labeler code 42513): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 42513
- Products in commercial distribution
- 20
- Packages
- 72
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 13, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 20 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 20 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 20 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Afoxolaner | 42513-0020 | Powder | Bulk ingredients | August 14, 2024 |
| Fluralaner | 42513-0019 | Powder | Bulk ingredients | January 5, 2023 |
| Moxidectin | 42513-0018 | Powder | Bulk ingredients | December 5, 2021 |
| Moxidectin | 42513-0018 | Powder | Bulk ingredients | December 5, 2021 |
| Dalbavancin hydrochloride | 42513-0017 | Powder | Bulk ingredients | January 29, 2021 |
| Acarbose | 42513-0016 | Powder | Bulk ingredients | January 28, 2021 |
| Daptomycin | 42513-0015 | Powder | Bulk ingredients | January 27, 2021 |
| Milbemycin oxime | 42513-0014 | Powder | Bulk ingredients | January 20, 2021 |
| Sirolimus | 42513-0013 | Powder | Bulk ingredients | January 20, 2021 |
| Telavancin hydrochloride | 42513-0012 | Powder | Bulk ingredients | September 7, 2020 |
| Tobramycin | 42513-0011 | Powder | Bulk ingredients | August 25, 2020 |
| Tobramycin sulfate | 42513-0009 | Powder | Bulk ingredients | April 1, 2020 |
| Milbemycin oxime | 42513-0010 | Powder | Bulk ingredients | June 1, 2016 |
| Gentamicin sulfate | 42513-0008 | Powder | Bulk ingredients | September 22, 2014 |
| Tobramycin sulfate | 42513-0009 | Powder | Bulk ingredients | August 28, 2014 |
| Colistimethate sodium | 42513-0007 | Powder | Bulk ingredients | November 14, 2013 |
| Vancomycin hydrochloride | 42513-0006 | Powder | Bulk ingredients | June 11, 2013 |
| Vancomycin hydrochloride, lyophilized | 42513-0005 | Powder | Bulk ingredients | June 11, 2013 |
| Daptomycin | 42513-0004 | Powder | Bulk ingredients | March 22, 2012 |
| Kanamycin sulfate | 42513-0002 | Powder | Bulk ingredients | August 13, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.